- Zimmermann P., Ziesenitz V.C., Curtis N., Ritz N. (2018): The immunomodulatory effects of macrolides—a systematic review of the underlying mechanisms. Front. Immunol. 9. 302.
- Andreani J., Le Bideau M., Duflot I., Jardot P., Rolland C., Boxberger M. (2020): In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect. Microb. Pathog. 145.104228.
- Du X., Zuo X., Meng F., Wu F., Zhao X., Li C. (2020): Combinatorial screening of a panel of FDA-approved drugs identifies several candidates with anti-Ebola activities. Biochem. Biophys. Res. Commun. 522. 862–868.
- Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M. (2020): Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 56. 105949 .
- El-Shitany N.A., El-Desoky K. (2016): Protective effects of carvedilol and vitamin C against azithromycin-induced cardiotoxicity in rats via decreasing ROS, IL1-β, and TNF-α production and inhibiting NF-κB and caspase-3 expression. Oxidative Med. Cell. Longev. 2016:1874762.
- Patel H., Calip G.S., DiDomenico R.J., Schumock G.T., Suda K.J., Lee T.A. (2019): Prevalence of cardiac risk factors in patients prescribed azithromycin before and after the 2012 FDA warning on the risk of potentially fatal heart rhythms. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 40. 107–115.
- Durrington PN, Mackness B, Mcknesss MI, (2011): Paraoxanase and atherosclerosis. Atheroscler Thromb Vasc Biol. 21. 473–480.
- Bouitbir J, Charles AL, Echaniz-Laguna A, Kindo M, Daussin F, Auwerx J, Piquard F, Geny B, Zoll J. (2012): Opposite effects of statins on mitochondria of cardiac and skeletal muscles: A ‘mitohormesis’ mechanism involving reactive oxygen species and pgc-1 Eur Heart J . 33. 1397-1407.
- Gao F, Ni Y, Luo Z, Liang Y, Yan Z, Xu X, Liu D, Wang J, Zhu S, Zhu Z. (2012): Atorvastatin attenuates tnf-alpha-induced increase of glucose oxidation through pgc-1alpha upregulation in cardiomyocytes. J Cardiovasc Pharmacol.59.500-506.
- Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R, Baigent C. (2012): The effects of lowering ldl cholesterol with statin therapy in people at low risk of vascular disease: Meta- analysis of individual data from 27 randomised trials. Lancet. 380. 581-590.
- Atli O., Ilgin S., Altuntas H., Burukoglu D. (2015): Evaluation of azithromycin induced cardiotoxicity in rats. Int. J. Clin. Exp. Med. 8. 3681–3690.
- Kim Y.-H., Park S.-M., Kim M., Kim S.H., Lim S.-Y., Ahn J.-C. (2012): Cardioprotective effects of rosuvastatin and carvedilol on delayed cardiotoxicity of doxorubicin in rats. Toxicol. Mech. Methods. 22. 488–498.
- Kiernan J K. (2001): Histological and Histochemical methods. In: Theory and practice. 3rd ed, London, New York, and New Delhy, Arnold Publisher.111-162 .
- Bancroft JD, Layton (2013): The hematoxylin and eosin, connective and mesenchymal tissues with their stains. In: Suvarna SK, Layton C and Bancroft JD, editors. Bancroft’s Theory and Practice of Histological Techniques. 7th edition, ch 10 and 11, Philadelphia, Churchill Living one. 173 – 212.
- Woods AE, Stirling JW, (2013): Transmission electron microscopy applications. In: Suvarna SK, Layton C, Bancroft JD, editors. Theory and Practical Histological Techniques. 7th edition, ch 22, Philadelphia, Churchill Living one; 493 – 538.
- Emsley R., Dunn G. and White I. (2010): Mediation and moderation of treatment effects in randomized controlled trials of complex interventions. Stat Methods Med Res. 19(3). 237–270.
- Ruan Q, Yang K, Wang W, Jiang L, Song J. (2020): Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 46. 846–848.
- Farías JG, Molina VM, Carrasco RA, Zepeda AB, Figueroa E, Letelier P. (2017): Antioxidant therapeutic strategies for cardiovascular conditions associated with oxidative stress. Nutrients. 9. 966.
- Yosef T, Damri O, Agam G.(2019): Dual role of autophagy in diseases of the central nervous system. Front Cell Neurosci. 13. 196.
- Dawood A and Hareedy H (2019): Differential effect of high fat diet (HFD) on the cardiac muscle of adult and aged female mice and the possible protective role of artichoke treatment: Histomorphometric and ultrastructural study. J Med Hist, Article 3, Volume 3, Issue 1, 36-54.
- Paradies G, Paradies V, Ruggiero FM, Petrosillo G.(2018): Mitochondrial bioenergetics and cardiolipin alterations in myocardial ischemia-reperfusion injury: implications for pharmacological cardioprotection. Am J Physiol Heart Circ Physiol. 315. 1342.
- Songbo M, Lang H, Xinyong C, Bin X, Ping Z, Liang S.(2019): Oxidative stress injury in doxorubicin-induced cardiotoxicity. Toxicol Lett. Vol: 307.Issue:48.
- -P. An, S.-K. An, X.-H. Wei, S.-Y. Fu, H.-A. Wu. (2015): Atorvastatin improves cardiac function of rats with chronic cardiac failure via inhibiting Rac1/P47phox/P67phox-mediated ROS release. 20. 3940-3946.
- Ramasubbu K, Estep J, White DL, Deswal A, Mann DL. (2008): Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. J Am Coll Cardiol .51. 415-426.
- Sharma H., Pathan R.A., Kumar V., Javed S., Bhandari U. (2011): Anti-apoptotic potential of rosuvastatin pretreatment in murine model of cardiomyopathy. Int. J. Cardiol. 150. 193–200.
- Anna B, Nikolas G. (2011): Aging and cardiac fibrosis. Aging and Disease. 2. 158-173.
- Lin J, Lopez EF, Yufang Jin Y, Remmen HV, Bauch T, Han HC , Lindsey ML.(2008): Age-Related Cardiac Muscle Sarcopenia: Combining experimental and mathematical modeling to identify mechanisms. Exp 43(4). 296–306.
- Datta S, Cano M, Ebrahimi K, Wang L, Handa JT.(2017): The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD. Prog Retin Eye Res. 60. 218.
- Zeng H.-T, Zhao M, Zhang -X, Liu Z.-L, , Zhong S.-M. (2019): Atorvastatin improves the cardiac function of rats after acute myocardial infarction through ERK1/2 pathway. 23(16):7120-7127.
|